Four new biomarkers may enable an earlier stomach cancer diagnosis

Australian researchers say they've zeroed in on four new biomarkers that could enable a simple blood test for the early diagnosis of stomach cancer, far earlier and more precise than existing standards of care. The University of Adelaide team said the proteins--afamin, clusterin, haptoglobin and vitamin D binding protein--each worked better than using the standard CA72-4 as a biomarker to distinguish patients with stomach cancer from healthy controls. They found differences in those four protein levels in blood samples from 37 gastric cancer patients, including 11 with early stage cancer. Details are published in the journal Biochimica et Biophysica Acta. Release | Journal abstract

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.